Skip to main content
. 2018 Oct 26;97(43):e12858. doi: 10.1097/MD.0000000000012858

Figure 6.

Figure 6

Sensitivity analysis for all eligible studies investigating the association between PD-L1 expression and OS and PFS in patients with OC. (A) Includes those studies evaluating OS; (B) includes those studies evaluating PFS. OC = ovarian carcinoma, OS = overall survival, PD-L1 = programmed cell death ligand 1, PFS = progression-free survival.